EG19436A - Process for preparing of new xamthine derivatives. - Google Patents

Process for preparing of new xamthine derivatives.

Info

Publication number
EG19436A
EG19436A EG75090A EG75090A EG19436A EG 19436 A EG19436 A EG 19436A EG 75090 A EG75090 A EG 75090A EG 75090 A EG75090 A EG 75090A EG 19436 A EG19436 A EG 19436A
Authority
EG
Egypt
Prior art keywords
treating
formamide
excess
compounds
making
Prior art date
Application number
EG75090A
Other languages
English (en)
Original Assignee
Almiral S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almiral S A Lab filed Critical Almiral S A Lab
Application granted granted Critical
Publication of EG19436A publication Critical patent/EG19436A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Peptides Or Proteins (AREA)
EG75090A 1989-12-27 1990-12-20 Process for preparing of new xamthine derivatives. EG19436A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929208A GB8929208D0 (en) 1989-12-27 1989-12-27 New xanthine derivatives

Publications (1)

Publication Number Publication Date
EG19436A true EG19436A (en) 1995-02-28

Family

ID=10668520

Family Applications (1)

Application Number Title Priority Date Filing Date
EG75090A EG19436A (en) 1989-12-27 1990-12-20 Process for preparing of new xamthine derivatives.

Country Status (30)

Country Link
US (1) US5223504A (ko)
EP (1) EP0435811B1 (ko)
JP (1) JPH089617B2 (ko)
KR (1) KR970001528B1 (ko)
CN (1) CN1029967C (ko)
AT (1) ATE93860T1 (ko)
AU (1) AU635104B2 (ko)
BR (1) BR9007258A (ko)
CA (1) CA2045478C (ko)
CZ (1) CZ278328B6 (ko)
DE (1) DE69003087T2 (ko)
DK (1) DK0435811T3 (ko)
EG (1) EG19436A (ko)
ES (1) ES2058864T3 (ko)
FI (1) FI96207C (ko)
GB (1) GB8929208D0 (ko)
HU (2) HU208825B (ko)
IE (1) IE64065B1 (ko)
IL (1) IL96708A (ko)
MX (1) MX23884A (ko)
MY (1) MY105303A (ko)
NO (1) NO178111C (ko)
NZ (1) NZ236517A (ko)
PL (1) PL166152B1 (ko)
PT (1) PT96332B (ko)
RU (1) RU2073679C1 (ko)
SK (1) SK278365B6 (ko)
UA (1) UA32512C2 (ko)
WO (1) WO1991009859A1 (ko)
ZA (1) ZA9010240B (ko)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521315A (en) * 1993-01-12 1996-05-28 Cell Therapeutics, Inc. Olefin substituted long chain compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247116T1 (de) 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
CA2206804C (en) 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
JPH11505241A (ja) * 1995-05-19 1999-05-18 カイロサイエンス・リミテッド キサンチン類およびこれらの治療的使用
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) * 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
AU722480B2 (en) * 1996-11-01 2000-08-03 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US5874437A (en) * 1996-11-01 1999-02-23 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
GB9623859D0 (en) * 1996-11-15 1997-01-08 Chiroscience Ltd Novel compounds
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
CA2372850C (en) * 1999-05-04 2011-01-18 Ulrich Kilian Synergistic combination comprising roflumilast and a pde-3 inhibitor
KR100701904B1 (ko) 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
KR20040007596A (ko) * 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 골절 치료 촉진용 조성물
JP4510383B2 (ja) * 2001-05-23 2010-07-21 田辺三菱製薬株式会社 軟骨疾患修復治療用組成物
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103764672A (zh) 2011-03-01 2014-04-30 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
AR115689A1 (es) 2018-07-05 2021-02-17 Sumitomo Chemical Co Compuestos de uracilo y su utilización
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
CH629788A5 (de) * 1977-07-20 1982-05-14 Lonza Ag Verfahren zur herstellung von 5,6-diaminouracil.
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds

Also Published As

Publication number Publication date
MY105303A (en) 1994-09-30
HUT57766A (en) 1991-12-30
DK0435811T3 (da) 1993-11-01
CA2045478A1 (en) 1991-06-28
ATE93860T1 (de) 1993-09-15
WO1991009859A1 (en) 1991-07-11
NO913236L (no) 1991-08-19
FI914014A0 (fi) 1991-08-26
CN1029967C (zh) 1995-10-11
FI96207C (fi) 1996-05-27
NO178111C (no) 1996-01-24
MX23884A (es) 1993-09-01
US5223504A (en) 1993-06-29
NO178111B (no) 1995-10-16
SK278365B6 (en) 1997-01-08
HU208825B (en) 1994-01-28
PL166152B1 (en) 1995-04-28
JPH05500226A (ja) 1993-01-21
BR9007258A (pt) 1992-02-25
CZ278328B6 (en) 1993-11-17
IL96708A0 (en) 1991-09-16
IE64065B1 (en) 1995-07-12
FI96207B (fi) 1996-02-15
IL96708A (en) 1994-06-24
NZ236517A (en) 1992-09-25
EP0435811A1 (en) 1991-07-03
IE904634A1 (en) 1991-07-17
HU211573A9 (en) 1995-12-28
AU6976891A (en) 1991-07-24
UA32512C2 (uk) 2001-02-15
JPH089617B2 (ja) 1996-01-31
CN1052858A (zh) 1991-07-10
DE69003087D1 (de) 1993-10-07
PT96332A (pt) 1991-09-30
GB8929208D0 (en) 1990-02-28
RU2073679C1 (ru) 1997-02-20
NO913236D0 (no) 1991-08-19
AU635104B2 (en) 1993-03-11
KR970001528B1 (ko) 1997-02-11
EP0435811B1 (en) 1993-09-01
ES2058864T3 (es) 1994-11-01
ZA9010240B (en) 1991-10-30
KR920701207A (ko) 1992-08-11
DE69003087T2 (de) 1993-12-16
PT96332B (pt) 1998-06-30
CA2045478C (en) 1998-12-29

Similar Documents

Publication Publication Date Title
EG19436A (en) Process for preparing of new xamthine derivatives.
GR3018891T3 (en) New arylethenylene derivatives and process for their preparation
HU912676D0 (en) Sulfonamide derivatives
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
HUT53099A (en) Process for producing new tetrahydrobenzimidazole derivatives and pharmaceutical compositions comprising such compounds
IE45700L (en) PYRAZOLO (3,4-b) PYRIDINES
PT81371A (en) Method for the preparation of indane derivatives
ES472290A1 (es) Un procedimiento para preparar un compuesto de benceno di- sustituido en orto
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
PL276046A1 (en) Method for manufacturing new derivatives of purine
US4100286A (en) 2-(Substituted heterocyclic amine)benzoic acids
US4066767A (en) 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them
HUP0203364A2 (hu) Eljárás 3-helyettesített-4-arilkinolin-2-on származékok előállítására
DE68928127D1 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
ES8306733A1 (es) Derivados de anilina y sus sales.
PH27293A (en) Aryloxy arlthip heteroaryloxy heteroarylthio-alkenylene derivatives of amine and a method of use thereof
DK492687D0 (da) Indolquinoxaliner med substituenter i 6-stilling indeholdende cykliske grupper
HUT48201A (en) Herbicide comprising anilide derivatives and process for producing such compounds
MY104630A (en) 4(1h) ouinoline derivatives
ES8802296A1 (es) Un metodo para preparar un derivado de acido benzoico